Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank De Wolf

Showing results (21-30 of 105) with videos related to

Pageof 11
Sort By:
AIDS (London, England)|July 12, 2012
Increasing sexual risk behaviour among Dutch men who have sex with men: mathematical models versus prospective cohort dataArd van Sighem, Iralice Jansen, Daniela Bezemer, et al.
Epidemics|March 1, 2011
27 years of the HIV epidemic amongst men having sex with men in the Netherlands: an in depth mathematical model-based analysisDaniela Bezemer, Frank de Wolf, Maarten C Boerlijst, et al.
Plos One|July 2, 2016
How Can Viral Dynamics Models Inform Endpoint Measures in Clinical Trials of Therapies for Acute Viral Infections?Carolin Vegvari, Christoforos Hadjichrysanthou, Emilie Cauët, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 28, 2005
Mortality in patients with successful initial response to highly active antiretroviral therapy is still higher than in non-HIV-infected individualsArd van Sighem, Sven Danner, Azra C Ghani, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 2, 2018
Inflammatory markers and the risk of dementia and Alzheimer's disease: A meta-analysisSirwan K L Darweesh, Frank J Wolters, M Arfan Ikram, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 29, 2004
Virologic and immunologic response to highly active antiretroviral therapy in indigenous and nonindigenous HIV-1-infected patients in the NetherlandsJeannine F Nellen, Ferdinand W Wit, Frank De Wolf, et al.
Plos One|June 23, 2016
Using Clinical Trial Simulators to Analyse the Sources of Variance in Clinical Trials of Novel Therapies for Acute Viral InfectionsCarolin Vegvari, Emilie Cauët, Christoforos Hadjichrysanthou, et al.
Journal of Theoretical Biology|November 5, 2002
Antigen-driven T-cell turnoverChristophe Fraser, Neil M Ferguson, Frank De Wolf, et al.
Alzheimer'S Research & Therapy|June 15, 2020
The dynamics of biomarkers across the clinical spectrum of Alzheimer's diseaseChristoforos Hadjichrysanthou, Stephanie Evans, Sumali Bajaj, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 2, 2011
Immunodeficiency as a risk factor for non-AIDS-defining malignancies in HIV-1-infected patients receiving combination antiretroviral therapyAnouk Kesselring, Luuk Gras, Colette Smit, et al.
Pageof 11

Showing results (21-30 of 105) with videos related to

Sort By:
Pageof 11
AIDS (London, England)|July 12, 2012
Increasing sexual risk behaviour among Dutch men who have sex with men: mathematical models versus prospective cohort dataArd van Sighem, Iralice Jansen, Daniela Bezemer, et al.
Epidemics|March 1, 2011
27 years of the HIV epidemic amongst men having sex with men in the Netherlands: an in depth mathematical model-based analysisDaniela Bezemer, Frank de Wolf, Maarten C Boerlijst, et al.
Plos One|July 2, 2016
How Can Viral Dynamics Models Inform Endpoint Measures in Clinical Trials of Therapies for Acute Viral Infections?Carolin Vegvari, Christoforos Hadjichrysanthou, Emilie Cauët, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 28, 2005
Mortality in patients with successful initial response to highly active antiretroviral therapy is still higher than in non-HIV-infected individualsArd van Sighem, Sven Danner, Azra C Ghani, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 2, 2018
Inflammatory markers and the risk of dementia and Alzheimer's disease: A meta-analysisSirwan K L Darweesh, Frank J Wolters, M Arfan Ikram, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 29, 2004
Virologic and immunologic response to highly active antiretroviral therapy in indigenous and nonindigenous HIV-1-infected patients in the NetherlandsJeannine F Nellen, Ferdinand W Wit, Frank De Wolf, et al.
Plos One|June 23, 2016
Using Clinical Trial Simulators to Analyse the Sources of Variance in Clinical Trials of Novel Therapies for Acute Viral InfectionsCarolin Vegvari, Emilie Cauët, Christoforos Hadjichrysanthou, et al.
Journal of Theoretical Biology|November 5, 2002
Antigen-driven T-cell turnoverChristophe Fraser, Neil M Ferguson, Frank De Wolf, et al.
Alzheimer'S Research & Therapy|June 15, 2020
The dynamics of biomarkers across the clinical spectrum of Alzheimer's diseaseChristoforos Hadjichrysanthou, Stephanie Evans, Sumali Bajaj, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 2, 2011
Immunodeficiency as a risk factor for non-AIDS-defining malignancies in HIV-1-infected patients receiving combination antiretroviral therapyAnouk Kesselring, Luuk Gras, Colette Smit, et al.
Pageof 11